You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiogenesis Inhibitor

Showing 1 - 25 of 8,383
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced

Recruiting
  • Esophageal Neoplasms
  • an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Apr 21, 2022

NSCLC Trial in Tianjin (Tislelizumab, Pemetrexed, Bevacizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 11, 2022

Sarcoma, Soft Tissue Trial in Worldwide (Nintedanib, Ifosfamide)

Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
Sep 10, 2021

Advanced Renal Cell Carcinoma Trial (Sunitinib, Trebananib)

Completed
Has Results
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 10, 2020

Ovarian Tumors, Fallopian Tube Tumors, Tumors by Site Trial (Drug: Anlotinib, Drug: Carboplatin/Paclitaxel)

Not yet recruiting
  • Ovarian Neoplasms
  • +14 more
  • Drug: Anlotinib
  • Drug: Carboplatin/Paclitaxel
  • (no location specified)
Mar 17, 2021

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Breast Cancer Stage II Trial in Xi'an (Anlotinib)

Recruiting
  • Breast Cancer Stage II
  • Xi'an, Shannxi Province, China
    Xijing Hospital Affiliated to Air Force Military Medical Univers
Sep 25, 2022

Adenocarcinoma of the Lung Trial in China (Camrelizumab, Albumin Paclitacxel, Apatinib)

Not yet recruiting
  • Adenocarcinoma of the Lung
  • Fuzhou, Fujian, China
  • +4 more
Jul 1, 2020

Therapeutic Combination in Advanced or Metastatic Kidney Cancer

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Blood collection
  • Tumour samples
  • Paris, France
  • +1 more
Mar 9, 2022

Small Cell Lung Cancer Trial in Suzhou (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Suzhou University
Jul 19, 2022

Sarcoma Trial in Seoul (Durvalumab, pazopanib)

Recruiting
  • Sarcoma
  • Durvalumab, pazopanib
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 21, 2021

Small Cell Lung Cancer Trial in Beijing (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 8, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

Endometriosis Trial in Boston (Cabergoline 0.5 MG, Placebo - Cap)

Recruiting
  • Endometriosis
  • Cabergoline 0.5 MG
  • Placebo - Cap
  • Boston, Massachusetts
  • +1 more
Mar 16, 2021

Sarcoma Trial in Shanghai (Apatinib monotherapy)

Recruiting
  • Sarcoma
  • Apatinib monotherapy
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiao Tong University School of Medicine
May 18, 2022

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Dermatomyositis Trial in Nanchang (Lenalidomide)

Not yet recruiting
  • Dermatomyositis
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Aug 3, 2022

Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Kansas City, Kansas
  • +3 more
May 12, 2023

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)

Recruiting
  • Colorectal Cancer
  • HAIC
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 15, 2022

Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)

Active, not recruiting
  • Prostatic Neoplasms
  • Low Grade Prostate Cancer
  • Dietary intervention first
  • Drug (Dutasteride) intervention first
  • Quebec, Canada
  • +1 more
Mar 14, 2022

Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Tumor Trial in Wuhan (68Ga-FAPI, PET/CT)

Recruiting
  • Fibroblast Activation Protein Inhibitor
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Aug 27, 2021

Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • (no location specified)
Nov 1, 2023

Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer and

Recruiting
  • Non Small Cell Lung Cancer
  • immune therapy
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jan 5, 2022